
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>Amlodipine</td><td>Pioglitazone</td><td>The risk or severity of hypoglycemia can be increased when Amlodipine is
combined with Pioglitazone.</td></tr><tr><td>Atorvastatin</td><td>Pioglitazone</td><td>The metabolism of Atorvastatin can be decreased when combined with Pioglitazone.</td></tr><tr><td>Dapagliflozin</td><td>Amlodipine</td><td>The risk or severity of hypoglycemia can be increased when Amlodipine is
combined with Dapagliflozin.</td></tr><tr><td>Dapagliflozin</td><td>Doxazosin</td><td>The risk or severity of adverse effects can be increased when Doxazosin is
combined with Dapagliflozin.</td></tr><tr><td>Dapagliflozin</td><td>Pioglitazone</td><td>Dapagliflozin may increase the hypoglycemic activities of Pioglitazone.</td></tr><tr><td>Doxazosin</td><td>Amlodipine</td><td>The metabolism of Doxazosin can be decreased when combined with Amlodipine.</td></tr><tr><td>Nebivolol</td><td>Dapagliflozin</td><td>The therapeutic efficacy of Dapagliflozin can be increased when used in
combination with Nebivolol.</td></tr><tr><td>Nebivolol</td><td>Doxazosin</td><td>The therapeutic efficacy of Nebivolol can be decreased when used in combination
with Doxazosin.</td></tr><tr><td>Nebivolol</td><td>Pioglitazone</td><td>The therapeutic efficacy of Pioglitazone can be increased when used in
combination with Nebivolol.</td></tr><tr><td>Pantoprazole</td><td>Amlodipine</td><td>The metabolism of Pantoprazole can be decreased when combined with Amlodipine.</td></tr><tr><td>Pantoprazole</td><td>Atorvastatin</td><td>The excretion of Atorvastatin can be decreased when combined with Pantoprazole.</td></tr><tr><td>Pantoprazole</td><td>Doxazosin</td><td>The metabolism of Doxazosin can be decreased when combined with Pantoprazole.</td></tr><tr><td>Pantoprazole</td><td>Nebivolol</td><td>The metabolism of Nebivolol can be decreased when combined with Pantoprazole.</td></tr><tr><td>Semaglutide</td><td>Amlodipine</td><td>The risk or severity of hypoglycemia can be increased when Amlodipine is
combined with Semaglutide.</td></tr><tr><td>Semaglutide</td><td>Dapagliflozin</td><td>Dapagliflozin may increase the hypoglycemic activities of Semaglutide.</td></tr><tr><td>Semaglutide</td><td>Nebivolol</td><td>The therapeutic efficacy of Semaglutide can be increased when used in
combination with Nebivolol.</td></tr><tr><td>Semaglutide</td><td>Pioglitazone</td><td>The risk or severity of hypoglycemia can be increased when Pioglitazone is
combined with Semaglutide.</td></tr><tr><td>Tenofovir alafenamide</td><td>Amlodipine</td><td>The metabolism of Tenofovir alafenamide can be decreased when combined with
Amlodipine.</td></tr><tr><td>Tenofovir alafenamide</td><td>Atorvastatin</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Atorvastatin.</td></tr><tr><td>Tenofovir alafenamide</td><td>Doxazosin</td><td>The metabolism of Tenofovir alafenamide can be decreased when combined with
Doxazosin.</td></tr><tr><td>Tenofovir alafenamide</td><td>Pantoprazole</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Pantoprazole.</td></tr></tbody></table></div>
